Silicon nitride spinal implants
Commercial- Indications
- Spinal fusion
Company intelligence / Profile preview
Sintx Technologies has developed and commercialized silicon nitride-based medical devices that are FDA-cleared and have been used clinically since 2008. The company’s products are recognized for their durability, biocompatibility, and antimicrobial properties. Recent strategic updates indicate revenue growth driven by increased demand in biomedical applications[4]. No clinical trial results typical of drug development companies; instead, clinical use data supports product safety and efficacy.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sintx Technologies, Inc..